Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Why MacroGenics Soared Nearly 9% Higher Today
Tickers MGNX RHHBY
Tags Market News MGNX RHHBY
From Motley Fool
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Tickers ABSI ABT AZN BIVI
Tags KZR MGTX FDA
From Benzinga
Roche Beefs Up PCR-Test Portfolio With TIB Molbiol Acquisition
Tickers RHHBF RHHBY RHHVF
Tags Benzinga Diagnostics Briefs
From Benzinga
2 Stocks I Bought Last Week
Tickers AZN JYNT NVAX PIRS
Tags SGEN SHOP JYNT
From Motley Fool
MacroGenics' Cancer Drug Margenza Flops On Overall Survival Analysis
Tickers MGNX RHHBF RHHBY RHHVF
Tags Trading Ideas breast cancer News
From Benzinga
7 Meme Stocks You Should Keep a Close Eye on for Real Potential
Tickers AMZN FORD GM HOOD
Tags TSM GM RHHBY
From InvestorPlace
Why Adaptimmune Therapeutics Stock Is Bolting Higher Today
Tickers ADAP RHHBY
Tags ADAP RHHBY Market News
From Motley Fool
Adaptimmune Stock Moves Higher On Cancer Deal With Genentech
Tickers ADAP RHHBF RHHBY RHHVF
Tags RHHBY RHHVF Small Cap
From Benzinga
Roche's Spark Therapeutics, NeuExcell Join Forces To Develop Huntington's Disease Gene Therapy
Tickers RHHBF RHHBY RHHVF
Tags RHHBY RHHVF Market News
From Benzinga
Is Exelixis Stock a Buy?
Tickers EXEL RHHBY
Tags Market News BAYR/Y RHHBY
From Motley Fool
COVID 19 Stocks -- Vaccines, Diagnostics, or Treatments?
Tickers ABT CDNA GH GILD
Tags Market News GILD CDNA
From Motley Fool
Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
Tickers ABBV ASND BGNE BIIB
Tags ABBV MIRM BGNE
From Benzinga
See Why AC Immune Stock Is Trading Higher After Data From Alzheimer's Candidate
Tickers ACIU RHHBF RHHBY RHHVF
Tags Alzheimer's disease Health Care Benzinga
From Benzinga
After Bladder Cancer, Roche Pulls Breast Cancer Indication For Tecentriq In US
Tickers RHHBF RHHBY RHHVF
Tags Market News FDA Benzinga
From Benzinga
Which Biotech Stock Will Shock the Market in 2022?
Tickers AXSM AZN NDAQ NVAX
Tags RHHBY AZN NVAX
From Motley Fool
Shape Therapeutics, Roche Form $3B RNA Editing Collaboration
Tickers RHHBF RHHBY RHHVF
Tags RHHVF RHHBY Gene Editing
From Benzinga
Why Shares of Global Blood Therapeutics Are Soaring Today
Tickers CRSP GBT RHHBY VRTX
Tags CRSP RHHBY VRTX
From Motley Fool
UK Approves Regeneron - Roche's COVID-19 Antibody Cocktail
Tickers REGN RHHBF RHHBY RHHVF
Tags Briefs News RHHBF
From Benzinga
Could Biogen Acquire Axsome Therapeutics?
Tickers AXSM BIIB LLY RHHBY
Tags AXSM RHHBY LLY
From Motley Fool
Roche's Arthritis Drug, Used As COVID-19 Treatment, Faces Supply Shortage
Tickers RHHBF RHHBY RHHVF SNY
Tags News Briefs SNY
From Benzinga
AstraZeneca, Daiichi Sankyo's Enhertu Shows Improved PFS Over Roche's Kadcyla In Breast Cancer
Tickers AZN DSKYF DSNKY RHHBF
Tags Briefs News breast cancer
From Benzinga
Genentech's Polivy Plus R-CHP Shows Prolonged Survival In Newly Diagnosed DLBCL Patients
Tickers RHHBF RHHBY RHHVF
Tags RHHVF RHHBY General
From Benzinga
Here Are the Winners of Cowen's Big Pharma R&D Showdown
Tickers ABBV COWN LLY MRK
Tags NVS ABBV RHHBY
From Motley Fool
These OTC Securities Had the Most Trading Activity in July
Tickers BDRBF CLXPF ETHE FNMA
Tags Markets BDRBF News
From Benzinga
Illumina Stock Will Be Unstoppable Once the Grail Acquisition Gets Approved
Tickers EXAS GH ILMN NTRA
Tags Market News NASDAQ:ILMN,NASDAQ:EXAS,OTC: RHHBY,NASDAQ:GH,NASDAQ: NTRA, NYSE: NVTA EXAS
From InvestorPlace
Pfizer's CEO Wants to Go Shopping: 3 Potential Companies on His Radar
Tickers AUPH AVIR AZN BPMC
Tags PFE RHHBY LLY
From Motley Fool
Moderna Vs. BioNTech: How Do These High-Flying COVID-19 Vaccine Stocks Compare?
Tickers BNTX MRNA PFE RHHBY
Tags Biotech Benzinga Health Care
From Benzinga
Billionaire Masayoshi Son's SoftBank Claims $5B Stake In Roche: Bloomberg
Tickers ABCL PACB RHHBF RHHBY
Tags Bloomberg SFTBY RHHBY
From Benzinga
This High-Risk, High-Reward Biotech Could Make COVID Less Deadly -- and Make Investors Money
Tickers AVIR GILD MRK RHHBY
Tags RHHBY GILD AVIR
From Motley Fool
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Tickers ABSI ACET ADCT ADVM
Tags NVTA RVVTF MYGN
From Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.